Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BostonGene

< Previous 1 2 Next >
Frost & Sullivan Recognizes BostonGene with Frost & Sullivan’s Enabling Technology Leadership Award for Revolutionizing Precision Oncology Diagnostics
From BostonGene
Via Business Wire
BostonGene Bolsters Leadership Team to Accelerate Innovation and Growth
From BostonGene
Via Business Wire
BostonGene to Showcase Comprehensive Portfolio of Advanced Diagnostic Tools and Technologies at the 21st Japanese Society of Medical Oncology Annual Meeting
From BostonGene
Via Business Wire
BostonGene Demonstrates Benefits of Integrated Tumor Tissue and Blood Profiling at SLAS2024 International Conference and Exhibition
From BostonGene
Via Business Wire
BostonGene and Duke University Announce Master Collaboration Agreement
From BostonGene
Via Business Wire
GlobalData Names BostonGene Leading Innovator in AI-Driven Drug Repurposing
From BostonGene
Via Business Wire
BostonGene Announces Publication in Blood
From BostonGene
Via Business Wire
Sarcoma Oncology Center Leverages BostonGene’s AI-Driven Molecular and Immune Profiling Platform to Identify Novel Treatment Options for Patients with Advanced Cancers
From BostonGene
Via Business Wire
BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition
From BostonGene
Via Business Wire
BostonGene to Present at the 2023 San Antonio Breast Cancer Symposium
From BostonGene
Via Business Wire
BostonGene Wins Fierce Life Sciences Innovation Award for AI-Driven Clinical Trials Matching Algorithm
From BostonGene
Via Business Wire
BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual Meeting
From BostonGene
Via Business Wire
BostonGene and Weill Cornell Medicine to Showcase Poster Presentations on Transcriptome-based Tumor Microenvironment Classification for Advancement of Personalized Cancer Therapeutics at the 20th International Cancer Genome Consortium Scientific...
From BostonGene
Via Business Wire
LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial
From BostonGene
Via Business Wire
BostonGene Announces Poster Presentation at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
From BostonGene
Via Business Wire
BostonGene and FibroFighters Collaborate to Revolutionize Clinical Care for Patients with Fibrolamellar Carcinomas
From BostonGene
Via Business Wire
BostonGene and Exigent Research Announce Clinical Trial Agreement to Bring Molecular Testing to Community Settings
From BostonGene
Via Business Wire
BostonGene Announces Three Abstract Acceptances at ESMO Congress 2023
From BostonGene
Via Business Wire
BostonGene Announces Master Agreement With Johns Hopkins University School of Medicine
From BostonGene
Via Business Wire
BostonGene to Present Unique AI-Driven Bioinformatic Solutions at the Festival of Genomics & Biodata
From BostonGene
Via Business Wire
BostonGene to Showcase Integrated Approach to Precision Medicine at the 82nd Annual Meeting of the Japanese Cancer Association
From BostonGene
Via Business Wire
BostonGene, NEC and JIP Form Joint Venture in Japan
From BostonGene
Via Business Wire
BostonGene to Present Approach for Patient Stratification and Selection of IO Clinical Trials Using Molecular and Immune Profiling at the 11th Annual Immuno-Oncology Summit
From BostonGene
Via Business Wire
BostonGene Announces the Launch of its CLIA-certified and CAP-accredited Liquid Biopsy, Immunoprofiling and Spatial Proteomics Solutions
From BostonGene
Via Business Wire
BostonGene Announces Six Abstract Acceptances at the 2023 American Society of Clinical Oncology Annual Meeting
From BostonGene
Via Business Wire
BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Announce Collaboration
From BostonGene
Via Business Wire
BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023
From BostonGene
Via Business Wire
BostonGene and Little Warrior Foundation Collaborate to Bring Novel Liquid Biopsy Solutions into Clinical Practice
From BostonGene
Via Business Wire
BostonGene to Present at the 2022 San Antonio Breast Cancer Symposium
From BostonGene
Via Business Wire
BostonGene Announces Publication in Cell Reports Revealing Spatial Heterogeneity in the Tumor Microenvironment of Multiregional Clear Cell Renal Cell Carcinoma Biopsies
From BostonGene
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.